- Home
- INSG vs NLSP Comparison
INSG vs NLSP Comparison
Compare INSG & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSG
- NLSP
- Stock Information
- Founded
- INSG 1996
- NLSP 2015
- Country
- INSG United States
- NLSP Switzerland
- Employees
- INSG N/A
- NLSP N/A
- Industry
- INSG Telecommunications Equipment
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- INSG Telecommunications
- NLSP Health Care
- Exchange
- INSG Nasdaq
- NLSP Nasdaq
- Market Cap
- INSG 230.9M
- NLSP 243.8M
- IPO Year
- INSG 2000
- NLSP 2021
- Fundamental
- Price
- INSG $12.17
- NLSP $3.43
- Analyst Decision
- INSG Buy
- NLSP
- Analyst Count
- INSG 3
- NLSP 0
- Target Price
- INSG $16.00
- NLSP N/A
- AVG Volume (30 Days)
- INSG 331.4K
- NLSP 629.5K
- Earning Date
- INSG 11-12-2024
- NLSP 11-29-2024
- Dividend Yield
- INSG N/A
- NLSP N/A
- EPS Growth
- INSG N/A
- NLSP N/A
- EPS
- INSG N/A
- NLSP N/A
- Revenue
- INSG $207,478,000.00
- NLSP N/A
- Revenue This Year
- INSG $13.25
- NLSP N/A
- Revenue Next Year
- INSG $5.55
- NLSP N/A
- P/E Ratio
- INSG N/A
- NLSP N/A
- Revenue Growth
- INSG 12.59
- NLSP N/A
- 52 Week Low
- INSG $1.60
- NLSP $3.00
- 52 Week High
- INSG $20.67
- NLSP $29.08
- Technical
- Relative Strength Index (RSI)
- INSG 36.44
- NLSP 39.10
- Support Level
- INSG $11.90
- NLSP $3.01
- Resistance Level
- INSG $13.48
- NLSP $3.55
- Average True Range (ATR)
- INSG 1.38
- NLSP 0.38
- MACD
- INSG -0.45
- NLSP 0.01
- Stochastic Oscillator
- INSG 17.88
- NLSP 32.09
About INSG Inseego Corp.
Inseego Corp is into the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by applications software and cloud services designed to enable customers to easily analyze data insights and configure and manage their hardware. It generates maximum revenue from United States and Canada. The company also has a presence in Australia and Europe (including United Kingdom).
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.